Table 4.
Rank | Counts | % of Total Publication (%) | Journal | Country | H-Index | IF (2021) | JCR (2021) | Total Citations | Average Citations |
---|---|---|---|---|---|---|---|---|---|
1 | 108 | 10.44 | Artificial cells nanomedicine and biotechnology | USA | 57 | 6.355 | Q1 | 108 | 2.63 |
2 | 30 | 2.90 | Shock | USA | 122 | 3.533 | Q2 | 228 | 7.6 |
3 | 28 | 2.71 | Transfusion | England | 138 | 3.337 | Q3 | 298 | 10.64 |
4 | 26 | 2.51 | Journal of Trauma and Acute Care Surgery | USA | 192 | 3.697 | Q2 | 340 | 13.08 |
5 | 25 | 2.42 | Artificial organs | England | 79 | 2.663 | Q3 | 209 | 8.71 |
6 | 21 | 2.03 | Anesthesia and analgesia | USA | 208 | 6.627 | Q1 | 309 | 14.71 |
7 | 20 | 1.93 | American journal of physiology heart and circulatory physiology | USA | 208 | 5.125 | Q1 | 324 | 16.2 |
8 | 18 | 1.74 | Biotechnology progress | USA | 135 | 2.909 | Q3 | 197 | 10.94 |
9 | 16 | 1.55 | Critical care medicine | USA | 282 | 9.296 | Q1 | 197 | 12.31 |
10 | 14 | 1.35 | Journal of applied physiology | USA | 240 | 3.88 | Q2 | 143 | 10.21 |
11 | 12 | 1.16 | Biochimica et biophysica acta proteins and proteomics | Netherland | 153 | 4.125 | Q3 | 149 | 12.42 |
12 | 12 | 1.16 | Free radical biology and medicine | USA | 277 | 8.101 | Q1 | 86 | 7.17 |
13 | 11 | 1.06 | Anesthesiology | USA | 245 | 8.986 | Q1 | 120 | 10.91 |
14 | 11 | 1.06 | Antioxidants redox signaling | USA | 203 | 7.468 | Q2 | 87 | 7.91 |
15 | 9 | 0.87 | Biomaterials | England | 397 | 15.304 | Q1 | 97 | 10.78 |
16 | 9 | 0.87 | Microvascular research | USA | 93 | 3.75 | Q3 | 98 | 10.89 |
17 | 8 | 0.77 | Biochemistry | USA | 260 | 3.321 | Q3 | 56 | 7 |
18 | 8 | 0.77 | Biotechnology and bioengineering | Germany | 198 | 4.395 | Q3 | 27 | 3.38 |
19 | 8 | 0.77 | Clinical chemistry | USA | 226 | 12.167 | Q1 | 95 | 11.88 |
20 | 8 | 0.77 | Critical care clinics | England | 76 | 3.879 | Q2 | 61 | 7.63 |
Abbreviations: HBOCs, hemoglobin-based oxygen carriers; IF, impact factor; JCR, journal citation reports; Q, quartile in category.